Are Our Bodies Destroying our Minds?

[DIGEST: The Scientist, Technology Review, Inverse, Science]

Can the underlying cause of neurological disorders like Alzheimer’s and Parkinson’s be traced back to our own immune system?

Diseases like Alzheimer’s are attributed to a buildup of proteins in the brain that form plaques and tangles, leading to the loss of brain connections. But scientist Beth Stevens theorizes that the underlying cause of degenerative neural conditions takes place well before the buildup of proteins. Stevens, along with researchers from MIT and Harvard, believe that aberrant synaptic elimination is to blame.

Beth Stevens. (CREDIT: Source.)

Our brains are constantly undergoing a process in which weak or damaged synapses are cleared out or “pruned” to keep everything running smoothly. The cells responsible for pruning faulty synapses are called microglia, and until recently they’ve been largely overlooked by the scientific community.

Microglia were previously thought to be nothing more than a sort of neurological janitorial service. When brain cells are damaged, microglia gobble up the injured bits while another type of glia called astrocytes creates scar tissue. The process is known as gliosis.

Stevens’ mentor, Stanford biologist Ben Barres, has been studying microglia for decades. “It was just really fascinating,” he says. “The great mystery was: what is the point of

this gliosis? Is it good? Is it bad? Is it driving the disease process, or is it trying to repair the injured brain?”

Barres found that a protein called C1q that marks injured or unused cells for elimination triggers the pruning process. To keep the flow of neural transmissions efficient, the brain needs only the synapses that are actually in use, so the C1q protein is integral to healthy brain development. But in fully-developed, healthy neurons, the C1q protein is virtually absent.

Ben Barres. (CREDIT: Source.)

Barres and Stevens conducted research on mice bred to develop neurological disorders. They found that not only was the C1q protein present in adult cells, but it also appeared before any other detectable sign of the disease. It was evident even before cells started dying.

Steven McCarroll, Ph.D. led a study identifying a similar protein, C4, that is activated in schizophrenic brains.

“I think the implication of that is they could be lifelong diseases,” says Barres. “The disease process could be going on for decades and the brain is just compensating, rewiring, making

new synapses.”

In January, Stevens, McCarroll and a team at the Broad Institute of MIT and Harvard published a paper showing that aberrant microglia can cause or contribute to massive cell loss leading to cognitive defects like schizophrenia.

Steven McCarroll and Beth Stevens. (CREDIT: Source.)

But what does that mean for treatment? Could devastating conditions like Alzheimer’s, schizophrenia and Parkinson’s be halted by the targeted suppression of synapse proteins?

Barres founded a company called Annexon Biosciences to develop a drug that could block C1q. Last week, Barres, Stevens and their colleagues published a paper showing that the drug was able to prevent mice bred to develop Alzheimer’s from showing signs of the disease.

The company hopes to start human trials in the next two years. “We’re a ways away from a cure,” says Stevens. “But we definitely have a path forward.”

Mandel Ngan/AFP via Getty Images

The United States, unlike North Korea and other nations President Donald Trump admires, does not have an official state media channel where the federal government can push propaganda.

But since his 2016 campaign, Trump has spoken as though he does have an official state media in Fox News.

Keep reading...
Leon Neal/Getty Images

Retired General John Kelly served as President Donald Trump's Chief of Staff until late 2018, and now he's siding against Trump on a crucial point.

Former National Security Advisor John Bolton's allegations in his upcoming memoir have rocked the impeachment trial in the Senate. Bolton claims Trump sought to withhold aid from Ukraine until it acquiesced to performing politically beneficial investigations for Trump's reelection bid.

Keep reading...

As calls continue to grow for former National Security Advisor John Bolton to testify before the Senate in President Donald Trump's impeachment trial, Trump's personal lawyer Rudy Giuliani is feeling left out.

Demands for Bolton's testimony skyrocketed among the public after allegations in his upcoming memoir that Trump sought to withhold Ukrainian aid as late as September to secure foreign investigations into Trump's political rivals.

Keep reading...
Fox News

Explosive allegations from an upcoming memoir by former National Security Advisor John Bolton are strengthening the case for additional witnesses at the Senate impeachment trial of President Donald Trump.

According to Bolton's manuscript, the President sought as recently as September to withhold $391 million in congressionally approved aid to Ukraine until its President announced investigations into his political rival, former Vice President Joe Biden.

Keep reading...
Scott Olson/Getty Images // Drew Angerer/Getty Images

The defense team in President Donald Trump's impeachment trial spent its second day of arguments defending Rudy Giuliani, bashing House Democrats, and ignoring bombshell developments regarding former National Security Advisor John Bolton that broke in the days before.

The team went after a familiar target in a performance that was likely for an audience of one: Donald Trump.

Keep reading...

Ken Starr, a conservative pundit and frequent Fox News guest, is best known for his dogged attacks to find impeachable offenses by President Bill Clinton during a multi-year investigation into every aspect of the Clinton family's lives.

In the end, Starr found an extramarital affair which was used to impeach Clinton and that Clinton lied under oath about his personal life.

Keep reading...